Brixmor Property Group Inc. ("Brixmor" or the "Company") announced today its operating results for the three and twelve months ended December 31, 2024. For the three months ended December 31, 2024 ...
Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuticals blocks sodium channels in the peripheral nervous system, preventing ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuticals blocks sodium channels in the peripheral nervous system, preventing ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It's the first new pharmaceutical approach to ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to ...
Demolition crews tear down a building at the Old Poage Farm in Roanoke County on Monday. Tinder Gold just got a whole lot cheaper — from $108 down to $39.97 Tinder Gold just got a whole lot ...
Ready to start the day? From drinking lemon water to brushing your teeth the right way, here's what experts recommend making part of your morning routine. (Getty Creative) ...
Taking the time to enjoy a nutrient-rich breakfast can set the tone for the rest of your day. One healthy habit often leads to another, so you’re priming yourself to make healthier choices all ...
HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...
What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.
Along with its gene editing therapy Casgevy, Vertex is offering fertility preservation support for its patients—a program that the HHS claims violates anti-kickback statutes. In a court filing on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback